Supramolecular imaging agents targeting cancer biomarkers

24 January 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Mechanically interlocked molecules present opportunities to construct therapeutic drugs and diagnostic imaging agents but harnessing supramolecular chemistry to make biologically active molecules in water is a challenge. Here, we describe a rotaxane-based approach in the synthesis of radiolabelled proteins and peptides for molecular imaging of cancer-specific biomarkers in vivo. Host-guest chemistry with mono-functionalised beta-cyclodextrin, combined with curcurbit[6]uril catalysed cooperative capture synthesis, produced radioactive gallium-68 or zirconium-89-labelled metallo[4]rotaxanes. Simultaneous, one-pot radiolabelling and photochemical conjugation to monoclonal antibodies produced a viable radiotracer that was evaluated in vivo for quantitative positron emission tomography (PET) imaging of cancer biomarker expression. The rotaxane architecture can be easily tuned to accommodate different radioactive metal ion complexes, other proteins and peptide-based drugs, and fluorophores for optical detection. This technology provides a future platform to explore the use of mechanical bonding to optimise drug delivery, control metabolism and excretion profiles, and enhance the efficacy of tumour specific agents.

Keywords

Rotaxanes
molecular imaging
antibodies
Supramolecular chemistry
photoradiosynthesis

Supplementary materials

Title
Description
Actions
Title
Electronic Supplementary Information
Description
Supplementary information (PDF) is available and contains experimental details, NMR spectra, high-resolution mass spectrometry data and HPLC chromatograms for all compounds, as well as additional data from the radiochemistry, in vivo experiments, and DFT calculations.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.